Cited by 44Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchParkinson's Disease Mechanisms and Treatments

Preface

DIGIOVANNI, G, DIMATTEO, V, ESPOSITO, E·2008·Progress in Brain Research

Integrity signals

Registry

Crossref · 10.1016/s0079-6123(08)00931-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Serotonergic and dopaminergic markers are jointly present in their developmental origins, guidepost areas, as well as within the subdomains of the PFC, which is important for their intricate interaction later in life to establish higher cognitive functions.

    “Serotonergic and dopaminergic markers are jointly present in their developmental origins, guidepost areas, as well as within the subdomains of the PFC, which is important for their intricate interaction later in life to establish higher cognitive functions [209, 232–234].”

    From Development of prefrontal cortex (2022) · cites this paper as [232]

Cited by

Sorted by citations

Authors
DIGIOVANNI, G., DIMATTEO, V, & ESPOSITO, E.
Venue
Progress in Brain Research
Publisher
Elsevier
Published
2008
Volume
172
Pages
ix-ix
ISSN
0079-6123 (ISSN-L)
OpenAlex
W1268986240
Cited by
44
References
0
Citations by year
2026: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 2
Type
paratext
Language
en
Open access
closed
Locations
  • Progress in brain research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
serotonin-dopamine interaction, monoamines, schizophrenia, depression, drug abuse, attention deficit hyperactivity disorder, Parkinson's disease, Tourette syndrome, cognition, neuropsychiatry, neuroimaging, electrophysiology, neurochemistry
MeSH terms
Brain, Dopamine, Periodicals as Topic, Publishing, Serotonin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review